UFPT: Rounding Bottom detected on 7 Oct 2026

UFP Technologies has demonstrated strong upward momentum with a 23.2% post-Q2 2026 move. The rounding bottom pattern forms with current price at $302.87, positioned 10.58% below the 52-week high and 74.2% above the 52-week low—indicating mid-range consolidation. Structure score of 13.0/15 and breakout score of 12.0/13 suggest solid pattern integrity. Volume ratio of 1.18x normal confirms institutional participation. RSI at 60.1 shows neither overbought nor oversold conditions, with positive MACD histogram (1.866) signaling momentum continuation. Conservative target is $319.66, just 5.5% above current price.

UFP Technologies recently reported Q2 2026 results showing sales of US$173.96 million and net income of US$20.85 million, with earnings per share rising year-on-year. Argus recently raised its price objective for UFP Technologies to $334 on October 5, 2026, providing near-term catalyst support. Management announced in May 2026 that UFP is actively pursuing multiple acquisitions, with acquisition-driven growth expected to contribute meaningfully over coming years. In August 2026, UFP Technologies released updated investor presentation materials emphasizing its role in multiple medical and industrial markets. The healthcare sector backdrop is bearish (regime score -0.17), though broader market regime remains bullish (0.86).

A successful rounding bottom breakout would target $319.66—approximately 5.5% above current price and offering asymmetric risk-reward given the measured move structure. Volume confirmation requires sustained relative volume above 1.18x as price clears resistance at $262.26. The pattern invalidates decisively below key support at $173.86, representing approximately 42.6% downside from current levels. Win probability of 68.96% suggests this pattern has a two-thirds statistical edge. Historical rounding bottom data shows breakout success typically occurs with 3-5 days of above-average volume at breakout.

Healthcare sector headwinds (bearish regime) contrast with individual stock strength, creating rotational risk if sector momentum reverses. Customer concentration remains a key risk, with Intuitive Surgical, Stryker and other large accounts creating vulnerability to customer-specific disruptions. Integration risk from acquisition activity is a key factor for how the story plays out. Beta of 0.77 provides some downside protection, but elevated 20-day volatility at 22.35% means price swings could exceed 2.59% ATR moves. A February 2026 cyber incident did not materially affect systems, though future cybersecurity issues could pose risks. No imminent earnings until likely Q3 reporting, reducing near-term catalyst risk.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.